Korean Circulation Journal

  • 제47권2호
  • /
  • Pages.176-178
  • /
  • 2017
  • /
  • 1738-5520(pISSN)
  • /
  • 1738-5555(eISSN)
대한심장학회 (The Korean Society of Cardiology)
권호 표지
DOI QR코드

DOI QR Code

Impact of Chronic Kidney Disease in Patients Undergoing Percutaneous Coronary Intervention: Improved but Not Solved

  • Ryu, Jae Kean (Division of Cardiology, Department of Internal Medicine, Catholic University of Daegu, School of Medicine) ;
  • Lee, In Hee (Division of Nephrology, Department of Internal Medicine, Catholic University of Daegu, School of Medicine)
  • 투고 : 2017.01.12
  • 심사 : 2017.02.15
  • 발행 : 2017.03.31
⟨ 이전 논문 다음 논문 ⟩

초록

키워드

참고문헌

  1. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Hypertension 2003;42:1050-65. https://doi.org/10.1161/01.HYP.0000102971.85504.7c
  2. Muntner P, He J, Hamm L, Loria C, Whelton PK. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 2002;13:745-53.
  3. Weiner DE. Causes and consequences of chronic kidney disease: implications for managed health care. J Manag Care Pharm 2007;13(3 Suppl):S1-9.
  4. Reinecke H, Matzkies F, Fobker M, Breithardt G, Schaefer RM. Diabetic nephropathy, percutaneous coronary interventions, and blockade of the renin-angiotensin system. Cardiology 2005;104:24-30. https://doi.org/10.1159/000086050
  5. Abe M, Morimoto T, Akao M, et al. Relation of contrast-induced nephropathy to long-term mortality after percutaneous coronary intervention. Am J Cardiol 2014;114:362-8. https://doi.org/10.1016/j.amjcard.2014.05.009
  6. Kim SM, Tripathy DR, Park SW, et al. Impact of chronic kidney disease on clinical outcomes in diabetic patients undergoing percutaneous coronary intervention in the era of newer-generation drug-eluting stents. Korean Circ J 2017;47:222-30. https://doi.org/10.4070/kcj.2016.0312
  7. Rubenstein MH, Harrell LC, Sheynberg BV, Schunkert H, Bazari H, Palacios IF. Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era? Circulation 2000;102:2966-72. https://doi.org/10.1161/01.CIR.102.24.2966
  8. Peng JR, Chang CJ, Wang CL, Tung YC, Lee HF. Impact of chronic kidney disease on long-term outcome in coronary bypass candidates treated with percutaneous coronary intervention. Korean Circ J 2017;47:50-5. https://doi.org/10.4070/kcj.2016.0093
  9. Zhu ZB, Zhang RY, Zhang Q, et al. Moderate-severe renal insufficiency is a risk factor for sirolimus-eluting stent thrombosis. The RIFT Study. Cardiology 2009;112:191-9. https://doi.org/10.1159/000149571
  10. Lutz J, Menke J, Sollinger D, Schinzel H, Thurmel K. Haemostasis in chronic kidney disease. Nephrol Dial Transplant 2014;29:29-40. https://doi.org/10.1093/ndt/gft209